Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China · Delayed Price · Currency is CNY 7.50
+0.08 (1.08%)
Sep 18, 2026, 3:00 PM CST
SHA:600664 Market Cap
SHA:600664 has a market cap or net worth of 18.89 billion as of September 18, 2026. Its market cap has increased by 102.16% in one year.
Market Cap
18.89B
Enterprise Value
17.59B
Revenue
16.14B
Ranking
n/a
PE Ratio
37.82
Stock Price
7.50
ChartMarket Cap Chart
Since August 28, 2006, SHA:600664's market cap has increased from 7.45B to 18.89B, an increase of 153.47%. That is a compound annual growth rate of 4.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 18.89B | 117.39% |
| Dec 31, 2025 | 8.69B | -16.46% |
| Dec 31, 2024 | 10.40B | 23.17% |
| Dec 29, 2023 | 8.45B | 11.14% |
| Dec 30, 2022 | 7.60B | -15.00% |
| Dec 31, 2021 | 8.94B | 11.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Walvax Biotechnology | 21.29B |
| Shanghai Haoyuan Chemexpress | 21.07B |
| Hybio Pharmaceutical | 20.76B |
| Tasly Pharmaceutical Group | 20.71B |
| Livzon Pharmaceutical Group | 20.65B |
| Jilin Aodong Pharmaceutical Group | 20.59B |
| Guangdong Zhongsheng Pharmaceutical | 20.59B |
| Betta Pharmaceuticals | 19.87B |